Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors

Diagnosis and Management
Herausgeber: Beger, Hans G; Sarr, Michael G; Peng, Shu You; Neoptolemos, John P; Nakao, Akimasa

• Gebundenes Buch

Produktbeschreibung

Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors: Diagnosis and Management Edited by Hans G. Beger, Germany; Akimasa Nakao, Japan; John P. Neoptolemos, UK; Shuyou Peng, China; and Michael Sarr, USA. Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors: Diagnosis and Management is a modern, expertly crafted and clinically focused guide to the diagnosis, management and best-practice care of patients suffering from pancreatic cancer, cystic neoplasms and endocrine tumours. Packed with outstanding figures and with reference to the leading society guidelines, its main focus is on the many endoscopic and radiologic diagnostic techniques, medical and surgical management of both full-blown cancer and other tumors, and the risks of each form of treatment. Also covered in detail are issues of tumor recurrence and long-term outcome of treatment. Brought to you by highly skilled national and international leaders in the specialty and an experienced editor team, this is an invaluable guide to practicing gastroenterologists and surgeons in the hospital and clinical environment, as well as oncologists and endocrinologists managing patients with pancreatic tumorous lesions. Related titles The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, 2nd Edition Beger, 978-1-4051-4664-7, 2008

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Wiley
• Seitenzahl: 456
• Erscheinungstermin: 27. April 2015
• Englisch
• Abmessung: 254mm x 189mm x 27mm
• Gewicht: 1141g
• ISBN-13: 9780470673188
• ISBN-10: 0470673184
• Artikelnr.: 42195628

Autorenporträt

Hans G. Beger MD, FACS, Emeritus Professor of Surgery, Universitätsklinikum Ulm, Universität Ulm, Ulm, Germany. Akimasa Nakao MD, PhD, FACS, Professor Emeritus, Nagoya University; President, Nagoya Central Hospital, Nagoya, Japan. John P. Neoptolemos MA, MB, BChir, MD, FRCS, FMedSci, The Owen and Ellen Evans Chair of Surgery; NIHR Senior Investigator; NIHR Liverpool Pancreas Biomedical Research Unit, The Liverpool Clinical Trials Unit and Cancer Research UK; Cancer Trials Unit Director, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. Shu You Peng MD, FACS, FRCSG, ESA, Professor, Department of Surgery, Second Affi liated Hospital, Zhejiang University, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China. Michael G. Sarr MD, J.C. Masson Professor of Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Inhaltsangabe

Section 1: Ductal Adenocarcinoma of the Pancreas
1. Histologic Classification and Tumor Staging of Pancreatic Cancer
Akio Yanagisawa and Eiichi Konishi
2. What We Know about Carcinogenesis of Ductal Adenocarcinoma of the
Pancreas
C. J. Bruns, H. Niess, B. Schwarz, A. Kleespies, M. K. Angele and K.-W.
Jauch
3. Familiar Cancer of the Pancreas
Detlef K. Bartsch, Volker Fendrich and Peter Langer
4. Clinical, Laboratory and Radiologic Presentation of Pancreatic Cancer
Susumu Hijioka and Kenji Yamao
5. Standards of Oncologic Pancreatic Surgery
Zhi Ven Fong and Keith D. Lillemoe
6. Extended Resection for Pancreatic Cancer: Risk and Benefits
Akimasa Nakao
7. Risk/Benefit of Total Pancreatectomy for Pancreatic Cancer: Are There
Indications?
Ake Andrén-Sandberg and Ralf Segersvard
8. Is There a Benefit for Additional Arterial Resection of Ductal Cancer of
the Pancreas?
Satoshi Hirano and Takahiro Tsuchikawa
9. Who Benefits from Ultra-Radical Pancreatic Cancer Extirpation?
Akimasa Nakao
10. Risk and Results of Pancreatic Cancer Resection
Norbert Hüser, Volker Assfalg and Helmut Friess
11. Pancreatic Cancer: The Role of Bypass Procedures
J.A.M.G. Tol, O.R.C. Busch, T.M. van Gulik and D.J. Gouma
12. Evidence of Adjuvant Chemotherapy of Ductal Pancreatic Cancer
Asma Sultana, Christopher Halloran, Daniel Palmer, Paula Ghaneh Trevor Cox
and John P Neoptolemos
13. Neoadjuvant Chemo- and Radio-Chemotherapy: Is There a Survival
Advantage for Pancreatic Cancer Patients
Susan Tsai, Ben George, Kathleen K. Christians and Douglas B. Evans
14. Standards of Palliative Chemotherapy and Chemoradiotherapy of Local
Advanced Pancreatic Cancer, Side Effects and Survival Benefits
Hana Algül and Roland M. Schmid
15. Management of Local and Distant Recurrence after Pancreatic Cancer
Resection
Takuji Okusaka, Kenji Hashimoto, Tomoko Katsui Taniyama, Hideki Ueno,
Chigusa Morizane, Shunsuke Kondo, Shuichi Mitsunaga, Satoshi Shimizu, Izumi
Ohno, Hideaki Takahashi and Masafumi Ikeda
16. Survival 3-, 5- and 10-years after Adjuvant Regional and Neoadjuvant
Chemotherapy in Resectable Pancreatic Cancer Patients: an Institutional
Experience
Osamu Ishikawa, Hiroaki Ohhigashi and Hidenori Takahashi
17. Non-ductal Primary Malignancies of the Pancreas: Acinus Cell Carcinoma
Marius Distler and Robert Grutzmann
18.Non-ductal Primary Malignancies of the Pancreas: Metastatic Malignancies
Victor Zaydfudim, Michael B. Farnell and Michael G. Sarr
Section 2: Periampullary Cancers
19. Histopathology of Tumor of the Ampulla of Vater
Li-rong Chen
20. Clinics of Periampulary Cancer
Cai Xiujun
21. Adenoma of the Papilla of Vater and Endoscopic Management
Takao Itoi and Shujiro Tsuji
22. Controversies about Local or Regional Treatment of Adenoma of the
Papilla of Vater: Japanese Experience
Takehiro Ota, Masakazu Yamamoto and Ken Takasaki
23. Cancer of the Papilla: Surgical Management
Hans G. Beger Q L Qiao and B Poch
24. Evidence of Surgical Management of Distal Common Bile Duct Cancer
Yingbin Liu and Wenguang Wu
25. Evidence of Surgical Management of Duodenum Cancer
Rory L. Smoot and Florencia G. Que
26. Survival and Chance of Cure after Surgery, Adjuvant and Palliative
Chemotherapy of Periampullary Tumors
Hao ran Qian and Shu You Peng
Section 3: Cystic Neoplastic Lesion of the Pancreas
27. Histologic Classification and Staging of Cystic Neoplastic Lesions of
the Pancreas
Rondell Graham and Tom Smyrk
28. Clinical Presentation of Cystic Neoplasms of the Pancreas
Masao Tanaka
29. EUS and Cystic Fluid Analysis of the Pancreas: Evidence of Diagnostic
Measures
Won Jae Yoon and William R. Brugge
30. Natural History of IPMN: Adenoma/Carcinoma Sequence in IPMN
Masanori Sugiyama and Yutaka Suzuki
31. What are the Pathologic Criteria that Justified Observational
Management in Patients with Cystic Naoplastic Lesions of the Pancreas?
Klaus Sahora, and Carlos Fernández-del Castillo
32. Indication for Operative Intervention of Cystic Neoplasms of the
Pancreas
George H. Sakorafas and Vassileios Smyrniotis
33. Surgical Management of IPMN Lesions of the Pancreas
Marcus C.B. Tan and Peter J. Allen
34. Surgical Management of MCN Lesions of the Pancreas
Klaus Sahora and Carlos Fernández-del Castillo
35. Surgical Management of SCA of the Pancreas
Giuseppe Malleo, Claudio Bassi and Roberto Salvia
36. Surgical Management of SPsN of the Pancreas
Song Cheol Kim
37. Limited Oncologic Resection or Major Surgery of Cystic Neoplasms of the
Pancreas?
Hans G Beger, Yang Yinmo, and Akimasa Nakao
38. Enucleation of Cystic Neaplasia of the Pancreas?
Janak A. Parikh and C. Max Schmidt
39. Long-Term Outcome after Observation and Surgical Treatment of the
Cystic Neoplasms of the Pancreas
Giuseppe Malleo, Roberto Salvia and Claudio Bassi
Section IV: Endocrine Neoplasms of the Pancreas
40. Classification of Endocrine Tumors of the Pancreas
J. J. Mukherjee and K. O. Lee
41. Clinical Manifestation of Endocrine Tumors of the Pancreas
K. O. Lee
42. Evidence of Hormonal, Laboratory, Bio-Chemistric and Instrumental
Diagnostics of Endocrine Tumors of the Pancreas
C.E.D.Ng, J. J. Mukherjee and K.O. Lee
43. Evidence of Medical and Radionucleotide Treatment of Endocrine Tumors
of the Pancreas
David C.E. Ng., J. J. Mukherjee and K.O. Lee
44. Insulinoma: Evidence of Surgical Treatment
Y. P. Mou
45. Gastrinoma: Evidence of Surgical Treatment
R. Y. Qin
46. Rare Endocrine Tumors of the Pancreas: Evidence of Management
Jiang Tao Li, Shu You Peng and De Fei Hong
47. Long-term Outcome after Clinical Management of Endocrine Tumors of the
Pancreas
Bin Xu and Jian Wei Wang
Section V: Chronic Pancreatitis with Inflammatory Tumor of the Pancreas
48. Chronic Pancreatitis with Inflammatory Mass in the Pancreatic Head
Ulrich F. Wellner and Tobias Keck
49. Chronic Tropical Pancreatitis: Clinical syndromes, natural course
management principles
Savio G. Barreto and Shailesh V. Shrikhande
50. Laboratory, Endoscopic and Radiologic Diagnostic of Chronic
Pancreatitis with Inflammatory Mass in the Head
J. Enrique Domínguez-Munoz, Julio Iglesias-Garcia and José Larino-Noia
51. Autoimmune Pancreatitis : How to Recognize this Entity and Avoid
Surgical Treatment
Raghuwansh P. Sah and Suresh T. Chari
52. What is the Place of Interventional-Endoscopic Treatment in Chronic
Pancreatitis/Inflammatory Tumor of the Pancreatic Head?
Yoshiki Hirooka and Hidemi Goto
53. When to Change from Conservative to Surgical Management in Alcoholic
Chronic and Tropical Chronic Pancreatitis
Shailesh V. Shrikhande and Savio G. Barreto
54. Duodenum Preserving Pancreatic Head Resection of Chronic Pancreatits
with Inflammatory Mass
Hans G. Beger and Qiao Qilu
55. Major Resection for Chronic Pancreatitis
John C. McAuliffe and John D. Christein
56. Short-term and Long-term Outcome after Interventional and Surgical
Treatment of Chronic Pancreatitis with Inflammatory Mass
Volker Assfalg, Norbert Hüser and Helmut Friess